Halimeter ppb levels as the predictor of erosive gastroesophageal reflux disease

Gut and Liver

Volumn 4, Issue 3, 2010, Pages 320-325

  Kim, Jung Gon ^a   Kim, Yoon Jae ^a   Yoo, Seung Hee ^b   Lee, So Jung ^a   Chung, Jun Won ^a   Kim, Min Ho ^c   Park, Dong Kyun ^a   Hahm, Ki Baik ^a  

^a Inha University School of Medicine   (South Korea)

^b The Catholic University of Korea   (South Korea)

^c CHA Bundang Medical Center   (South Korea)

Author keywords

Body mass index; Gastroesophageal reflux disease; H2S; Halitosis; Hiatal hernia; Nonerosive gastroesophageal reflux disease; Volatile sulfur compound

Indexed keywords

UNCLASSIFIED DRUG; VOLATILE AGENT; VOLATILE SULFUR CONTAINING COMPOUND;

ACID ASPIRATION; ADULT; ARTICLE; BODY MASS; DISEASE SEVERITY; DYSPEPSIA; EQUIPMENT; EROSIVE GASTROESOPHAGEAL REFLUX; FEMALE; GAS CHROMATOGRAPHY; GASTROESOPHAGEAL REFLUX; GASTROSCOPY; HALIMETER; HALITOSIS; HEARTBURN; HUMAN; MAJOR CLINICAL STUDY; MALE; NON EROSIVE REFLUX DISEASE; STOMACH JUICE;

EID: 77957599900     PISSN: 19762283     EISSN: None     Source Type: Journal    
DOI: 10.5009/gnl.2010.4.3.320     Document Type: Article

References (27)

1. Meskin LH. A breath of fresh air. J Am Dent Assoc 1996;127:1282, 1284, 1286.
2. Scully C, el-Maaytah M, Porter SR, Greenman J. Breath odor: etiopathogenesis, assessment and management. Eur J Oral Sci 1997;105:287-293.
3. Van Steenberghe D. Breath maldor. Curr Opin Periodontol 1997;4:137-143.
4. Tangerman A. Halitosis in medicine: a review. Int Dent J 2002;52(Suppl 3):201-206.
5. Feller L, Blignaut E. Halitosis: a review. SADJ 2005;60:17-19.
6. Porter SR, Scully C. Oral malodour (halitosis). BMJ 2006; 333:632-635.
7. Tonzetich J. Production and origin of oral malodor: a review of mechanisms and methods of analysis. J Periodontol 1977;48:13-20.
8. Katz J, Shenkman A, Stavropoulos F, Melzer E. Oral signs and symptoms in relation to disease activity and site of involvement in patients with inflammatory bowel disease. Oral Dis 2003;9:34-40.
9. Hoshi K, Yamano Y, Mitsunaga A, Shimizu S, Kagawa J, Ogiuchi H. Gastrointestinal diseases and halitosis: association of gastric Helicobacter pylori infection. Int Dent J 2002;52 Suppl 3:207-211.
10. Moshkowitz M, Horowitz N, Leshno M, Halpern Z. Halitosis and gastroesophageal reflux disease: a possible association. Oral Dis 2007;13:581-585.
11. Tonzetich J. Direct gas chromatographic analysis of sulphur compounds in mouth air in man. Arch Oral Biol 1971;16:587-597.
12. Richter VJ, Tonzetich J. The application of instrumental technique for the evaluation of odoriferous volatiles from saliva and breath. Arch Oral Biol 1964;9:47-54.
13. Yoo SH, Jung HS, Sohn WS. Volatile sulfur compounds as a predictor for esophagogastroduodenal mucosal injury. Gut Liver 2008;2:113-118.
14. Lee JS, Kwon KA, Jung HS, Kim JH, Hahm KB. Korea red ginseng on Helicobacter pylori-induced halitosis: newer therapeutic strategy and a plausible mechanism. Digestion 2009;80:192-199.
15. Hong SP, Park PW, Hwang SG, et al. Significance of non-erosive minimal esophageal lesions in gastro-esophageal reflux disorder. Korean J Intern Med 2004;19:93-98.
16. Armstrong D, Bennett JR, Blum AL, et al. The endoscopic assessment of esophagitis: a progress report on observer agreement. Gastroenterology 1996;111:85-92.
17. Hoshihara Y, Hashimoto M. Endoscopic classification of reflux esophagitis. Nippon Rinsho 2000;58:1808-1812.
18. DiBaise JK. The LA classification for esophagitis: a call for standardization. Am J Gastroenterol 1999;94:3403-3404.
19. Savas N, Dagli U, Sahin B. The effect of hiatal hernia on gastroesophageal reflux disease and influence on proximal and distal esophageal reflux. Dig Dis Sci 2008;53:2380-2386.
20. Gordon C, Kang JY, Neild PJ, Maxwell JD. The role of the hiatus hernia in gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2004;20:719-732.
21. Stuhlmeier KM, Bröll J, Iliev B. NF-kappaB independent activation of a series of proinflammatory genes by hydrogen sulfide. Exp Biol Med (Maywood) 2009;234:1327-1338.
22. Zhang H, Bhatia M. Hydrogen sulfide: a novel mediator of leukocyte activation. Immunopharmacol Immunotoxicol 2008;30:631-645.
23. Andruski B, McCafferty DM, Ignacy T, Millen B, McDougall JJ. Leukocyte trafficking and pain behavioral responses to a hydrogen sulfide donor in acute monoarthritis. Am J Physiol Regul Intergr Comp Physiol 2008;295:R814-R820.
24. Tamizhselvi R, Moore PK, Bhatia M. Hydrogen sulfide acts as a mediator of inflammation in acute pancreatitis: in vitro studies using isolated mouse pancreatic acinar cells. J Cell Mol Med 2007;11:315-326.
25. Friedenberg FK, Xanthopoulos M, Foster GD, Richter JE. The association between gastroesophageal reflux disease and obesity. Am J Gastroenterol 2008;103:2111-2122.
26. Corley DA, Kubo A. Body mass index and gastroesophageal reflux disease: a systematic review and metaanalysis. Am J Gastroenterol 2006;101:2619-2628. (Pubitemid 44665262)
27. Vaezi MF. Extraesophageal manifestations of gastroesophageal reflux diseases. Clin Cornerstone 2003;5:32-38.